1. Response of human tumor xenografts in athymic nude mice to docetaxel (RP 56976, Taxotere^®)

   • Donald J. Dykes
   • Marie Christine Bissery
   • William R. Waud

   Preclinical Studies Pages: 1 - 11

2. P-Glycoprotein mediated resistance to 5′-nor-anhydro-vinblastine (Navelbine^®)

   • David J. Adams
   • Vincent C. Knick

   Preclinical Studies Pages: 13 - 21

3. Preclinical antitumor activity of ethyldeshydroxysparsomycin in combination with cisplatin

   • H. P. Hofs
   • D. J. Th. Wagener
   • W. J. De Grip

   Preclinical Studies Pages: 23 - 32

4. Hepsulfam distribution in blood, plasma and cerebrospinal fluid of baboons

   • Milton V. Marshall
   • K. Dee Carey
   • John G. Kuhn

   Preclinical Studies Pages: 33 - 36

5. Binding of a new multidrug resistance modulator, S9788, to human plasma proteins and erythrocytes

   • Saïk Urien
   • Phuc Nguyen
   • Jean-Paul Tillement

   Preclinical Studies Pages: 37 - 41

6. Adenocarcinoma of unknown primary: retrospective analysis of chemosensitivity of 313 freshly explanted tumors in a tumor cloning system

   • Axel -R. Hanauske
   • Gary M. Clark
   • Daniel D. Von Hoff

   Preclinical Studies Pages: 43 - 49

7. Stimulation of tumor growthin vitro andin vivo by suramin on the VX2 model

   • Luis H. Ramirez
   • Morbize Juliéron
   • Jean-Nicolas Munck

   Brief Report Pages: 51 - 53

8. Phase I trial of pentosan polysulfate

   • Sandra M. Swain
   • Bernard Parker
   • Robert DeLap

   Phase I Studies Pages: 55 - 62

9. A phase I study of sulofenur in refractory pediatric malignant solid tumors

   • Charles B. Pratt
   • Laura C. Bowman
   • William H. Meyer

   Phase I Studies Pages: 63 - 66

10. Phase II trial and cost analysis of fazarabine in advanced non-small cell carcinoma of the lung: A southwest oncology group study

    • Stephen K. Williamson
    • John J. Crowley
    • John Wendall Goodwin

    Phase II Studies Pages: 67 - 71

11. Phase II study of cisplatin, 5-fluorouracil and interferon-α in recurrent carcinoma of the cervix

    • César Gonzales-de Léon
    • Scott M. Lippman
    • John J. Kavanagh

    Phase II Studies Pages: 73 - 76

12. A phase II trial of Doxorubicin HCl Liposome Injection in patients with advanced pancreatic adenocarcinoma

    • Gary K. Schwartz
    • Ephraim S. Casper

    Phase II Studies Pages: 77 - 82

13. A phase II trial of piroxantrone in disseminated malignant melanoma

    • J. A. Sosman
    • L. E. Flaherty
    • V. Sondak

    Phase II Studies Pages: 83 - 87

14. Experience of the treatment with Sehydrin (Hydrazine Sulfate, HS) in the advanced cancer patients

    • Vladimir A. Filov
    • Michail L. Gershanovich
    • Boris A. Ivin

    Phase II Studies Pages: 89 - 97

15. Pharmacology, relative bioavailability, and toxicity of three different oral cyclophosphamide preparations in a randomized, cross-over study

    • David J. Stewart
    • Lee Roy Morgan Jr
    • Marion Thibault

    Bioavailability Study Pages: 99 - 107

16. First announcement

    Announcements Pages: 109 - 109